Poor response to thiopurine in inflammatory bowel disease: how to overcome therapeutic resistance?

Clin Chem. 2013 Jul;59(7):1023-6. doi: 10.1373/clinchem.2012.195750.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Azathioprine / adverse effects
  • Azathioprine / blood
  • Azathioprine / therapeutic use*
  • Colitis, Ulcerative / drug therapy*
  • Drug Resistance
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Mercaptopurine / adverse effects
  • Mercaptopurine / blood
  • Mercaptopurine / therapeutic use*
  • Recurrence
  • Treatment Failure
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Mercaptopurine
  • Adalimumab
  • Azathioprine